We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

6 hedge funds and large institutions have $866K invested in Tenax Therapeutics in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.01% more ownership

Funds ownership: 0% → 0.01% (+0.01%)

41% less capital invested

Capital invested by funds: $1.47M → $866K (-$605K)

50% less funds holding

Funds holding: 12 → 6 (-6)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $12K

Holders
6
Holders Change
-6
Holders Change %
-50%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
1
Closed
9
Calls
–
Puts
$12K
Net Calls
-$12K
Net Calls Change
+$12K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$380K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$104K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$92.1K
4
VF
Virtu Financial
New York
+$80.6K
5
UBS Group
UBS Group
Switzerland
+$11.5K

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$297K
2
BBA
Baker Bros. Advisors
New York
-$171K
3
Millennium Management
Millennium Management
New York
-$80K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$67K
5
Citadel Advisors
Citadel Advisors
Florida
-$43K
Name Holding Trade Value Shares
Change 		Change in
Stake
FWP
1
FAS Wealth Partners
Kansas
$320K -$34.5K -3 -8%
Renaissance Technologies
2
Renaissance Technologies
New York
$313K +$380K +33 +1,100%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$80K +$104K +9 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$70K +$92.1K +8 New
VF
5
Virtu Financial
New York
$69K +$80.6K +7 +700%
UBS Group
6
UBS Group
Switzerland
$11K +$11.5K +1 New
BlackRock
7
BlackRock
New York
$3K – – –
AFM
8
Anson Funds Management
Texas
– -$297K -19 Closed
BBA
9
Baker Bros. Advisors
New York
– -$171K -11 Closed
Millennium Management
10
Millennium Management
New York
– -$80K -5 Closed
Bank of New York Mellon
11
Bank of New York Mellon
New York
– -$67K -4 Closed
Citadel Advisors
12
Citadel Advisors
Florida
– -$43K -3 Closed
Geode Capital Management
13
Geode Capital Management
Massachusetts
– -$36K -2 Closed
Northern Trust
14
Northern Trust
Illinois
– -$25K -2 Closed
TSS
15
Two Sigma Securities
New York
– -$11K -1 Closed
Verition Fund Management
16
Verition Fund Management
Connecticut
– -$16K -1 Closed
CCMINC
17
Cardinal Capital Management Inc (North Carolina)
North Carolina
– -$5K – –
CCB
18
Cutter & Co Brokerage
Missouri
– -$7K – –

TENX Hedge Fund Activity: Q1 2018 in Review

6 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2018, worth a combined $866K — down 41% from $1.47M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of TENX and 3 opened new positions — a net loss of 6 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, adding an estimated $380K. The largest seller was Anson Funds Management, exiting entirely with an estimated $297K sold.

  • 6 institutional investors held Tenax Therapeutics (TENX) as of Q1 2018, down from 12 in Q4 2017.
  • Funds reported $866K of Tenax Therapeutics stock for Q1 2018, down 41% quarter-over-quarter.
  • 3 funds opened new Tenax Therapeutics positions in Q1 2018 and 9 closed out, a net change of -6 holders.
  • The largest Tenax Therapeutics buyer in Q1 2018 was Renaissance Technologies, an estimated $380K added.
  • The largest Tenax Therapeutics seller in Q1 2018 was Anson Funds Management, an estimated $297K sold.

Based on aggregated 13F filings for Q1 2018.